Lipoxin A4 biology in the human synovium. Role of the ALX signaling pathways in modulation of inflammatory arthritis

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 3-4, 2005, Pages 189-196

  Fiore, S ^a   Antico, G ^a   Aloman, M ^a   Sodin Semrl, S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOXIN A; METALLOPROTEINASE; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; LIPOXIN; LIPOXIN RECEPTOR;

ARTHRITIS; B LYMPHOCYTE; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; COLITIS; CYTOKINE RELEASE; DNA BINDING; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; INFLAMMATION; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; BIOSYNTHESIS; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ARTHRITIS; CYTOKINES; HUMANS; LIPOXINS; NF-KAPPA B; RECEPTORS, LIPOXIN; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TRANSCRIPTION FACTOR AP-1; TRANSFORMING GROWTH FACTOR BETA;

EID: 24344444571     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.05.005     Document Type: Article

References (54)

1. C.O. Bingham The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation J. Rheumatol. 65 S 2002 3
2. K. Migita, S. Honda, S. Yamasaki, Y. Hirai, T. Fukuda, T. Aoyagi, M. Kita, H. Ida, T. Tsukada, A. Kawakami, Y. Kawabe, and K. Eguchi Regulation of rheumatoid synovial cell growth by ceramide Biochem. Biophys. Res. Commun. 269 2000 70
3. Y.T. Konttinen, T.-F. Li, M. Hukkanen, J. Ma, J-W. Xu, and I. Virtanen Fibroblastbiology. Signals targeting the synovial fibroblast in arthritis Arthritis Res. 2 2000 348
4. N. Kawanaka, M. Yamamura, T. Aita, Y. Morita, A. Okamoto, M. Kawashima, M. Iwahashi, A. Ueno, Y. Ohmoto, and H. Makino CDI4+,CDI6+ blood monocytes and joint inflammation in rheumatoid arthritis Arthritis Rheum. 46 2002 2578
5. R.J. Bischof, D. Zafiropoulos, J.A. Hamilton, and I.K. Campbell Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-I and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation Clin. Exp. Immunol. 119 2000 361
6. D.E. Woolley, and L.C. Tetlow Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion Arthritis Res. 2 2000 5
7. Y. Yamamura, R. Gupta, Y. Morita, X. He, R. Pai, J. Endres, A. Freiberg, K. Chung, and D.A. Fox Effector function of resting T cells: activation of synovial fibroblasts J. Immunol. 166 2001 2270
8. R.N. Maini, C. Plater-Zyberk, and E. Andrew Autoimmunity in rheumatoid arthritis. An approach via a study of B lymphocytes Rheum. Dis. Clin. North Am. 2 1987 319
9. G.S. Firestein Invasive fibroblast-like synoviocytes in rheumatoid arthritis Rheum. Arthritis 39 1996 I781
10. Y. Yamanishi, and G.S. Firestein Pathogenesis of rheumatoid arthritis: the role of synoviocytes Rheum. Dis. Clin. North Am. 2 2001 355
11. C. Georganas, H. Liu, H. Perlman, A. Hoffmann, B. Thimmapaya, and R.M. Pope Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: dominant role for NF-kB but not C/EBP or c-Jun J. Immunol. 165 2000 7199
12. M. Feldmann Pathogenesis of arthritis: recent research progress Nat. Immunol. 2 2001 771
13. N. Mukaida, A. Harada, K. Yasumoto, and K. Matsushima Properties of pro-inflammatory cell type-specific leukocyte chemotacticcytokines, interleukin 8 (lL-8) and monocyte chemotactic and activating factor (MCAF) Microbiol. Immunol. 36 1992 773
14. R. GiIlitzer, U. Ritter, U. Spandau, M. Goebeler, and E.B. Brocker Differential expression of GRO alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vi Yo J. Invest. Dermatol. 107 1996 778
15. R. Marok, P.G. Winyard, A. Coumbe, M.L. Kus, K. Gaffney, S. Blades, P.I. Mapp, C.J. Morris, D.R. Blake, C. Kaltschmidt, and P.A. Baeuerle Activation of the transcription factor nuclear factorkappaB in human inflamed synovial tissue Arthritis Rheum. 39 1996 583
16. Z. Han, L. Chang, Y. Yamanishi, M. Karin, and G.S. Firestein Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis Arthritis Rheum. 46 2002 81 88
17. Z. Han, D.L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, A.M. Manning, and G.S. Firestein c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis J. Clin. Invest. 108 2001 73
18. M. Karin, and M. Delhase The IB kinase (IKK) and NF-kB: key elements of proinflaminatory signalling Semin. Immunol. 12 2000 85
19. Z. Han, D.L. Boyle, A.M. Manning, and G.S. Firestein AP-I and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis Autoimmunity 28 1998 197
20. C. Tsai, L.A. Diaz Jr., N.G. Singer, L.L. Li, A.H. Kirsch, R. Mitra, B.J. Nickoloff, L.J. Crofford, and D.A. Fox Responsiveness of human Tlymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes Arthritis Rheum. 1ll.39 1996 125
21. J.W. Pierce, R. Schoenleber, G. Jesmok, J. Best, S.A. Moore, T. Collins, and M.E. Gerritsen Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo J. Biol. Chem. 272 1997 21096
22. P. Isomaki, and J. Punnonen Pro- and anti-inflammatory cytokines in rheumatoid arthritis Ann. Med. 29 1997 499
23. N. Alaaeddine, J.A. Di Battista, J.P. Pelletier, K. Kiansa, J.M. Cloutier, and J. Martel-Pelletier Differential effects of IL-8, LIF (pro-inflammatory) and IL-11 (anti-inflammatory) on TNF-alpha-induced PGE(2)release and on signalling pathways in human OA synovial fibroblast Cytokine 11 1999 1020
24. C.N. Serhan, and N. Chiang Lipid-derived mediators in endogenous anti-inflammation and resolution: Lipoxins and aspirin-triggered 15-epi-Lipoxins Scientific World J. 2 2002 169
25. C.N. Serhan Lipoxins and aspirin triggered 15-epi-lipoxin biosynthesis: an update and role in antiinflammation and pro-resolution Prostaglandins Other Lipid Mediat. 68 2002 433
26. T. Takano, S. Fiore, J.F. Maddox, H.R. Brady, N.A. Petasisand, and C.N. Serhan Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors J. Exp. Med. 185 1997 1693
27. C.B. Clish, J.A. O'Brien, K. Gronert, G.L. Stahl, N.A. Petasis, and C.N. Serhan Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo Proc. Natl. Acad.Sci. USA 96 1999 8247
28. S. Sodin-Semrl, B. Taddeo, D. Tseng, J. Varga, and S. Fiore Lipoxin A4 inhibits IL-I beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases J. Immunol. 164 2000 2660
29. S. Fiore, S. Sodin-Semrl, Y. Kang, and J. Varga Activation of LXA4R or serumamyloid A results in opposite regulation of NF-kB DNA binding in human synovial fibroblasts Arthritis Rheum. 43 2000 S158
30. P.R. Devchand, M. Arita, S. Hong, G. Bannenberg, R.L. Mousignac, K. Gronert, and C.N. Serhan Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense FASEB J. 17 2003 652
31. A.T. Gewirtz, L.S. Collier-Hyams, A.N. Young, T. Kucharzik, W.J. Guilford, J.F. Parkinson, I.R. Williams, A.S. Neishand, and J.L. Madara Lipoxin A4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis J. Immunol. 168 2002 5260
32. C.J. Furlaneto, and A. Campa A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-I beta, and interleukin-8 by human blood neutrophil Biochem. Biophys. Res. Commun. 268 2000 405
33. R. He, H. Sang, and R.D. Ye Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRLI/LXA4R Blood 101 2003 1572
34. H. Patel, R. Fellowes, S. Coade, and P. Woo Human serum amyloid A has cytokine-like properties Scand. J. Immunol. 48 1998 410
35. G. Cunnane, S. Grehan, S. Geoghegan, C. McCormack, D. Shields, A.S. Whitehead, B. Bresnihan, and O. Fitzgerald Serum amyloid A in the assessment of early inflammatory arthritis J. Rheumatol. 27 2000 58
36. C.M. Uhlar, and A.S. Whitehead Serum amyloid A, the major vertebrate acute-phase reactant Eur. J. Biochem. 265 1999 501
37. S.H. Yap, H.J. Moshage, B.P. Hazenberg, H.M. Roelofs, J. Bijzet, P.C. Limburg, L.A. Aarden, and M.H. van Rijswijk Tumor necrosis factor (TNF) inhibits interleukin (lL)-1 and/or IL-6 stimulated synthesis of C reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes Biochim. Biophys. Acta 1091 1991 405
38. N. Kalmovarin, W.E. Friedrichs, H.V. O'Brien, L.A. Linehan, B.H. Bowmanand, and F. Yang Extrahepatic expression of plasma protein genes during inflammation Inflammation 15 1991 369
39. S. Sodin-Semrl, A. Spagnolo, R. Mikus, R. Barbaro, J. Varga, and S. Fiore Opposing regulation of interleukin-8 and NF-kB responses by lipoxin A4 and seruma amyloid A via the common lipoxin A4 receptor Int. J. Immunopathol. Pharmacol. 17 2004 145 155
40. S. Fiore, and C.N. Serhan Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD 11b/18 expression by lipoxin A4-lipoxin A4 receptor interaction Biochemistry 34 1995 16678
41. Y.D. Jung, F. Fan, D.J. McConkey, M.E. Jean, W. Liu, N. Reinmuth, O. Stoeltzing, S.A. Ahmad, A.A. Parikh, N. Mukaida, and L.M. Ellis Role of P38 MAPK, AP-1, and NF-kappaB in interleukin-1 beta induced IL-8 expression in human vascular smooth muscle cells Cytokine 18 2002 206
42. S. Fiore, J.F. Maddox, H.D. Perezand, and C.N. Serhan Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor J. Exp. Med. 180 1994 253
43. S. Fiore, S.W. Ryeom, P.F. Weller, and C.N. Serhan Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils J. Biol. Chem. 267 1992 16168
44. I.M. Fierro, and C.N. Serhan Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins Braz. J. Med. Biol. Res. 34 2001 555
45. S. Mitchell, G. Thomas, K. Harvey, D. Cottell, K. Reville, G. Berlasconi, N.A. Petasis, L. Erwig, A.J. Rees, J. Savill, H.R. Brady, and C. Godson Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo J. Am. Soc. Nephrol. 13 2002 2497
46. I.M. Fierro, J.L. Kutok, and C.N. Serhan Novel lipid mediator regulators of endothelial cell proliferation andmigration: aspirin-triggered-15R-Lipoxin A4 and Lipoxin A4′ J. Pharmacol. Exp. Therap. 300 2002 385
47. B. McMahon, D. Mitchell, R. Shattock, F. Martin, H.R. Brady, and C. Godson Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation FASEB J. 16 2002 1817
48. S.B. Su, W. Gong, J.L. Gao, W. Shen, P.M. Murphy, J.J. Oppenheim, and J.M. Wang A seven transmembrane, G protein-coupled receptor, FPRLI, mediates the chemotactic activity of serum amyloid A for human phagocytic cells J. Exp. Med. 189 1999 395
49. N. Chiang, I.M. Fierro, K. Gronert, and C.N. Serhan Activation of lipoxin A(4) receptors by aspirin triggered lipoxins and select peptides evokes ligand specific responses in inflammation J. Exp. Med. 191 2000 1197
50. M. Resnati, I. Pallavicini, J.M. Wang, J. Oppenheim, C.N. Serhan, M. Romano, and F. Blasi The fibrinolytic receptor for urokinase activates the G protein coupled chemotactic receptor FPRL I/LXA4R Proc. Nat. Acad. Sci. USA 99 2002 1359
51. M. Perretti, N. Chiang, M. La, I.M. Fierro, S. Marullo, S.J. Getting, E. Solito, and C.N. Serhan Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor Nat. Med. 8 2002 1296
52. K. Migita, Y. Kawabe, M. Tominaga, T. Origuchi, T. Aoyagi, and K. Eguchi Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts Lab. Invest 78 1998 535
53. T.I. Mitchell, J.J. Jeffrey, R.D. Palmiter, and C.E. Brinckerhoff The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin Biochim. Biophys. Acta 1156 1993 245
54. S. Sodin-Semrl, A. Spagnolo, R. Barbaro, J. Varga, and S. Fiore Lipoxin A4 counteracts synergistic activation of human fibroblast-like synoviocytes Int. J. Immunopathol. Pharmacol. 17 2004 15 25